Home Cart 0 Sign in  

[ CAS No. 73548-77-3 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
Chemical Structure| 73548-77-3
Chemical Structure| 73548-77-3
Structure of 73548-77-3 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 73548-77-3 ]

Related Doc. of [ 73548-77-3 ]

Alternatived Products of [ 73548-77-3 ]

Product Details of [ 73548-77-3 ]

CAS No. :73548-77-3 MDL No. :MFCD03788041
Formula : C20H30N2O6 Boiling Point : -
Linear Structure Formula :- InChI Key :PUJVYJATJHQXRX-INIZCTEOSA-N
M.W : 394.46 Pubchem ID :11132998
Synonyms :
Chemical Name :(S)-Methyl 6-(((benzyloxy)carbonyl)amino)-2-((tert-butoxycarbonyl)amino)hexanoate

Calculated chemistry of [ 73548-77-3 ]

Physicochemical Properties

Num. heavy atoms : 28
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.55
Num. rotatable bonds : 15
Num. H-bond acceptors : 6.0
Num. H-bond donors : 2.0
Molar Refractivity : 104.17
TPSA : 102.96 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : No
P-gp substrate : Yes
CYP1A2 inhibitor : No
CYP2C19 inhibitor : Yes
CYP2C9 inhibitor : Yes
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -6.46 cm/s

Lipophilicity

Log Po/w (iLOGP) : 3.02
Log Po/w (XLOGP3) : 3.17
Log Po/w (WLOGP) : 3.0
Log Po/w (MLOGP) : 2.15
Log Po/w (SILICOS-IT) : 2.64
Consensus Log Po/w : 2.8

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 1.0
Egan : 0.0
Muegge : 0.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -3.45
Solubility : 0.14 mg/ml ; 0.000354 mol/l
Class : Soluble
Log S (Ali) : -5.0
Solubility : 0.00392 mg/ml ; 0.00000993 mol/l
Class : Moderately soluble
Log S (SILICOS-IT) : -5.17
Solubility : 0.0027 mg/ml ; 0.00000684 mol/l
Class : Moderately soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 1.0 alert
Leadlikeness : 2.0
Synthetic accessibility : 3.67

Safety of [ 73548-77-3 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P280-P301+P312-P302+P352-P305+P351+P338 UN#:N/A
Hazard Statements:H302-H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 73548-77-3 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 73548-77-3 ]
  • Downstream synthetic route of [ 73548-77-3 ]

[ 73548-77-3 ] Synthesis Path-Upstream   1~5

  • 1
  • [ 73548-77-3 ]
  • [ 2389-45-9 ]
Reference: [1] Journal of the Chemical Society - Perkin Transactions 1, 1996, # 10, p. 995 - 999
[2] Chemistry - A European Journal, 2014, vol. 20, # 5, p. 1258 - 1262
  • 2
  • [ 73548-77-3 ]
  • [ 27894-50-4 ]
Reference: [1] Tetrahedron Letters, 1998, vol. 39, # 31, p. 5631 - 5634
[2] Patent: EP1903034, 2008, A1, . Location in patent: Page/Page column 7
[3] Chemical Biology and Drug Design, 2012, vol. 79, # 4, p. 459 - 469
  • 3
  • [ 73548-77-3 ]
  • [ 55757-60-3 ]
YieldReaction ConditionsOperation in experiment
100% With palladium on activated charcoal; hydrogen In methanol at 20℃; for 0.666667 h; [0047] Intermediate 4 (839 mg, 2.1 mmol) was dissolved in methanol (15 mL). After adding Pd/C (catalytic amount), the mixture was stirred under hydrogen atmosphere at room temperature for 40 min. After confirming completion of the reaction by TLC (ethyl acetate:n-hexane=2:1), the reaction solution was filtered through a Celite pad. After evaporation under a reduced pressure, intermediate 5 (563 mg, q.y.) was obtained as a colorless oil, which was used as such in the next reaction.
Reference: [1] Patent: US2015/80551, 2015, A1, . Location in patent: Paragraph 0047
[2] Angewandte Chemie - International Edition, 2017, vol. 56, # 6, p. 1643 - 1647[3] Angew. Chem., 2017, vol. 129, # 6, p. 1665 - 1669,5
[4] Tetrahedron, 1982, vol. 38, p. 697
[5] Chemistry - A European Journal, 2011, vol. 17, # 18, p. 5011 - 5018
[6] European Journal of Organic Chemistry, 2002, # 23, p. 4063 - 4070
[7] Tetrahedron Letters, 1989, vol. 30, # 3, p. 313 - 316
[8] Journal of Medicinal Chemistry, 1984, vol. 27, # 7, p. 888 - 893
[9] Bioorganic and Medicinal Chemistry, 2006, vol. 14, # 18, p. 6349 - 6358
[10] Journal of Organic Chemistry, 1990, vol. 55, # 3, p. 870 - 876
[11] Patent: WO2010/48582, 2010, A1, . Location in patent: Page/Page column 168
[12] Angewandte Chemie - International Edition, 2010, vol. 49, # 18, p. 3211 - 3214
[13] Proceedings of the National Academy of Sciences of the United States of America, 2011, vol. 108, # 17, p. 6793 - 6798
[14] Chemical Biology and Drug Design, 2012, vol. 79, # 4, p. 459 - 469
[15] Angewandte Chemie - International Edition, 2013, vol. 52, # 27, p. 7033 - 7037[16] Angew. Chem., 2013, vol. 125, # 27, p. 7171 - 7175,5
[17] Patent: US2014/243527, 2014, A1, . Location in patent: Paragraph 0123
  • 4
  • [ 73548-77-3 ]
  • [ 82689-20-1 ]
Reference: [1] European Journal of Organic Chemistry, 2015, vol. 2015, # 12, p. 2654 - 2660
[2] Chemical and Pharmaceutical Bulletin, 1982, vol. 30, # 5, p. 1921 - 1924
  • 5
  • [ 73548-77-3 ]
  • [ 82689-20-1 ]
Reference: [1] Patent: US2002/22631, 2002, A1,
Same Skeleton Products
Historical Records